EVENT RECAP – Life Science Lectures: Episode Four “Leveraging early advice opportunities in EU HTA”
On 14 December, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs, hosted the fourth episode of its #LifeScienceLectures webinar series. The focus of the webinar, titled “Leveraging early advice opportunities in EU HTA” was to discuss how best to navigate early advice opportunities with the new EU health technology assessment (HTA), which will be mandatory for all new oncology products and ATMPs from 12 January 2025.
EUCOPE experts went over the opportunities for receiving joint scientific advice from EMA and HTA bodies in parallel in the interim period leading up to 2025, discuss the features and requirements of the procedure and strategic considerations for companies.
You can now watch the full webinar here: